Is screening for osteoporosis worthwhile?

Medicine and Dentistry

• Bone Density 100%
• Osteoporosis 100%
• Hormone Substitution 66%
• Fragility Fracture 66%
• Bone Mass 66%
• Injury 66%
• Drug Therapy 33%
• Screening 33%
• Cost-Effectiveness Analysis 33%
• Bisphosphonate 33%
• Selective Estrogen Receptor Modulator 33%
• Osteolysis 33%
• Disease 33%
• Bone Densitometry 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Replacement Therapy 100%
• Injury 100%
• Fragility Fracture 100%
• Bisphosphonic Acid Derivative 50%
• Disease 50%
• Selective Estrogen Receptor Modulator 50%

Keyphrases

• High-risk Strategy 100%
• Bone Density Screening 66%
• Compliance Level 33%
• Selective Estrogen Receptor Modulators 33%
• Policy Targets 33%
• Financial Implications 33%